Univariate analyses of acute GVHD and survival according to HLA disparity in the GVH direction
No. of HLA mismatches in the GVH direction . | Acute GVHD II-IV . | 2-year overall survival . | ||||
---|---|---|---|---|---|---|
n . | Cumulative incidence, % . | P . | n . | Survival rate, % . | P . | |
HLA-A, -B, -DR (antigen) | .08 | .5 | ||||
0 + 1 | 50 | 33 | 59 | 36 | ||
2 | 84 | 48 | 104 | 35 | ||
HLA-A, -B (class I antigen) | .5 | .2 | ||||
0 | 22 | 36 | 24 | 54 | ||
1 | 80 | 42 | 96 | 32 | ||
2 | 32 | 46 | 43 | 32 | ||
HLA-DR (class II antigen) | .5 | .9 | ||||
0 | 71 | 38 | 91 | 32 | ||
1 + 2 | 63 | 47 | 72 | 38 | ||
HLA-A, -B (antigen), -DR (allele) | .4 | 1.0 | ||||
0 + 1 | 25 | 32 | 29 | 38 | ||
2 | 48 | 51 | 60 | 38 | ||
3 + 4 | 30 | 44 | 38 | 39 | ||
HLA-A, -B, -DR (allele) | .3 | .4 | ||||
0 + 1 | 15 | 27 | 16 | 56 | ||
2 | 35 | 49 | 41 | 37 | ||
3 + 4 + 5 | 36 | 51 | 50 | 35 |
No. of HLA mismatches in the GVH direction . | Acute GVHD II-IV . | 2-year overall survival . | ||||
---|---|---|---|---|---|---|
n . | Cumulative incidence, % . | P . | n . | Survival rate, % . | P . | |
HLA-A, -B, -DR (antigen) | .08 | .5 | ||||
0 + 1 | 50 | 33 | 59 | 36 | ||
2 | 84 | 48 | 104 | 35 | ||
HLA-A, -B (class I antigen) | .5 | .2 | ||||
0 | 22 | 36 | 24 | 54 | ||
1 | 80 | 42 | 96 | 32 | ||
2 | 32 | 46 | 43 | 32 | ||
HLA-DR (class II antigen) | .5 | .9 | ||||
0 | 71 | 38 | 91 | 32 | ||
1 + 2 | 63 | 47 | 72 | 38 | ||
HLA-A, -B (antigen), -DR (allele) | .4 | 1.0 | ||||
0 + 1 | 25 | 32 | 29 | 38 | ||
2 | 48 | 51 | 60 | 38 | ||
3 + 4 | 30 | 44 | 38 | 39 | ||
HLA-A, -B, -DR (allele) | .3 | .4 | ||||
0 + 1 | 15 | 27 | 16 | 56 | ||
2 | 35 | 49 | 41 | 37 | ||
3 + 4 + 5 | 36 | 51 | 50 | 35 |